Mbb Public Markets I LLC Madrigal Pharmaceuticals, Inc. Transaction History

Mbb Public Markets I LLC

  • $1.69 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$120.4 - $237.13 $552,636 - $1.09 Million
-4,590 Reduced 76.63%
1,400 $323,000
Q3 2023

Nov 14, 2023
BUY
$146.04 - $225.78 $73,020 - $112,890
500 Added 9.11%
5,990 $874,000
Q2 2023

Aug 14, 2023
BUY
$203.88 - $312.0 $671,580 - $1.03 Million
3,294 Added 150.0%
5,490 $1.27 Million
Q1 2023

May 15, 2023
BUY
$231.06 - $307.08 $276,347 - $367,267
1,196 Added 119.6%
2,196 $532,000
Q4 2022

Feb 14, 2023
BUY
$58.39 - $296.54 $58,390 - $296,540
1,000 New
1,000 $290,000

Others Institutions Holding MDGL

# of Institutions
298
Shares Held
22M
Call Options Held
819K
Put Options Held
640K
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.76B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Mbb Public Markets I LLC Portfolio

Follow Mbb Public Markets I LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mbb Public Markets I LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mbb Public Markets I LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email